Tranexamic acid is safe to use following mild-to-moderate traumatic brain injury.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32161036.
- Also identified by DOI 10.1136/bmj.m514.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The studyThe CRASH-3 Trial Collaborators<u>. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.</u> <i>Lancet</i> 2019;394:1713-23.This trial was funded by NIHR Health Technology Assessment Programme (project number 14/190/01), JP Moulton Charitable Trust, Department of Health and Social Care, Department for International Development, Global Challenges Research Fund, Medical Research Council, and the Wellcome Trust (Joint Global Health Trials scheme).To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000870/tranexamic-acid-following-mild-to-moderate-traumatic-brain-injury-is-safe-and-reduces-deaths.
Medical subject headings
- Antifibrinolytic Agents
- Brain Injuries, Traumatic
- Vascular Diseases